Gastric Volvulus Treatment Market Report Evaluates Growth Drivers, Challenges And Market Dynamics

The gastric volvulus treatment market is on a promising growth trajectory, driven by advancements in medical technology and increasing clinical awareness. As the demand for effective and minimally invasive treatment options rises, this sector is expected to achieve significant milestones in the coming years. Here, we explore the market size forecast, major industry players, evolving trends, and the primary segments shaping the global gastric volvulus treatment landscape.

Projected Expansion of the Gastric Volvulus Treatment Market
The market for gastric volvulus treatment is anticipated to reach a value of $39.4 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3%. Several factors contribute to this upward trend, including the rising adoption of minimally invasive surgical techniques, advancements in emergency care protocols, the utilization of cutting-edge imaging technologies, the growth of specialty surgical centers, and heightened clinical awareness of gastric volvulus. Key developments expected to influence the market during this period involve increased preference for surgical interventions, widespread use of minimally invasive procedures, enhancements in emergency diagnosis and treatment, expansion of specialized surgical services, and an emphasis on rapid intervention to lower mortality rates.

The gastric volvulus treatment market size has grown strongly in recent years. It will grow from $28.86 billion in 2025 to $30.8 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to availability of surgical treatment options, hospital emergency care growth, diagnosis through imaging tests, development of gastropexy procedures, surgical expertise advancement.

Download a free sample of the gastric volvulus treatment market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp&utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Leading Organizations Driving the Gastric Volvulus Treatment Sector
The gastric volvulus treatment industry features several prominent companies, such as Medtronic plc, Johnson & Johnson Services Inc., Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co KG, Cook Group Incorporated, B Braun Melsungen AG, ConMed Corporation, Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation), Ambu A S, Richard Wolf GmbH, USGI Medical, Ovesco Endoscopy AG, Endo Tools Therapeutics SA, ErgoSuture, Sutrue Ltd, Golden Stapler Surgical Co Ltd, and TransEnterix Inc. A significant recent activity in this market occurred in January 2024 when Olympus Corporation, a Japan-based MedTech firm specialized in imaging and therapeutic solutions, acquired Taewoong Medical Co., Ltd. for about US$370 million. This acquisition aims to enhance Olympus's gastrointestinal endotherapy portfolio by incorporating Taewoong's advanced metallic stent technologies. Taewoong Medical, headquartered in China, produces a variety of gastrointestinal metallic stents designed for minimally invasive treatment in the biliary tract, esophagus, colon, and duodenum, targeting strictures and obstructions.

Innovations and Trends Shaping the Future of Gastric Volvulus Treatment
Industry leaders are actively working on innovative solutions to address the growing demand for advanced therapies that improve long-term disease management and quality of life for patients. One focus is on next-generation oral immunomodulatory treatments, which offer a more convenient, targeted approach to managing inflammatory and immune-related conditions compared to conventional systemic therapies that often involve more side effects and complex monitoring. A notable example is Pfizer Inc., a US pharmaceutical company, which received FDA approval in October 2023 for VELSIPITY (etrasimod), an oral sphingosine-1-phosphate (S1P) receptor activator intended for adults with moderate to severe active ulcerative colitis (UC). This once-daily medication, administered at a recommended dose of 2 mg, enables patients to achieve steroid-free remission with a favorable benefit-risk profile. The FDA's endorsement of VELSIPITY marks a critical advancement for UC patients requiring novel, effective therapies.

View the full gastric volvulus treatment market report:
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report?utm_source=Open&utm_medium=Paid&utm_campaign=Aug_PR

Segmentation Overview within the Global Gastric Volvulus Treatment Market
The gastric volvulus treatment market is classified across several core segments:
1) By Type: Organo-Axial Volvulus and Mesentero-Axial Volvulus
2) By Treatment Type: Medication and Surgery
3) By Route of Administration: Oral and Parenteral
4) By Distribution Channel: Hospital Pharmacy and Retail Pharmacy
5) By End-User: Hospitals, Homecare, Specialty Clinics, and Other End-Users

Further subcategories refine the classification:
- For Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, and Gastropexy
- For Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, and Endoscopic Techniques

These segments provide a comprehensive framework to understand the competitive landscape and therapeutic approaches within this specialized treatment market.

Key enhancements in our 2026 market reports include:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.